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ABSTRACT
The antibacterial and antifungal activity of zinc(lI) carboxylates with composition Zrl(RCOO)2nH20
(R =H-, CH.-, CH3CH2CH2-, (CH3)2CH-, XCH:-, X=CI, Br, I, n=0 or 2), [ZnX:(Nia+CH2COO):]
(Nia=nicotinamide, X=CI, Br, I)and [Zn(XCH:COO):(Caf):]o2H20 (Car=caffeine, X=CI, Br) is studied
against bacterial strains Staphylococcus aureus, Escherichia coil and yeast Candida albicans. The structural
types are assigned to the prepared compounds and the influence of (i) carboxylate chain length, (ii)
substitution of hydrogen atom of carboxylate by halogen and (iii) presence ofN-donor organic ligands on the
biological activity is discussed.
INTRODUCTION
Zinc is known to have a considerable effect on many biological processes. This element has structural
and gene-regulatory functions in living organisms and participates in catalysis of essential metabolic
reactions. It is known to regulate activity over 300 metalloenzymes [1, 2]. Zinc is a component of special
proteins, called "zinc fingers", which recognize DNA base sequence and thus serve in the selective activation
and regulatory control of gene transcription, i.e. zinc participates in the reliable transfer of genetic
information [3].
The wound-healing effect of zinc-containing ointments is known for several centuries [3]. The zinc
may be used as a therapeutic agent and it may act as an antisickling agent and play role in the prevention of
pain crisis in sickle-cell disease. Zinc was successfully used in the treatment of acrodermatitis enteropathica,
Wilson’s disease, gastrointestinal disorders, infertility and other diseases [4]. Very important is antibacterial
and antiviral effect of the zinc(ll) ion [5, 6].
Zinc(ll) complexes with organic molecules were also used in clinical medicine, e.g. complex of
zinc(ll) acetate with erythromycin is used for ache therapy [7]. In general, organic ligands can contribute to
better transport of metal ions through the lipophillic regions of cell membranes. However, it is also possible
that some metal complexes are not able to reach their site of action in sufficient concentration due to their
decreased solubility [8]. For the preparation of effective antimicrobial species it is very important to gain
knowledge about the structure and bonding relations in the compounds. It was found that the antibacterial
effect of various drugs could be enhanced when they are chelated to metal [9].
In order to understand properties of the zinc we have synthesized zinc(II) complexes with/without N-
donor organic ligands (nicotinamide, caffeine). Their structure and thermal properties have been described
elsewhere [10-17]. The present work deals with the study of the antibacterial and antifungal properties of
these reported compounds.
MATERIALS AND METHODS
The syntheses of the complexes have been described elsewhere [10-17]. All chemicals used in the
syntheses were analytical grade and purchased from Aldrich Chemical Company.
A Specord M80 Infrared Spectrophotometer was ased for infrared (IR) spectroscopic analyses. IR
spectra were obtained as KBr discs.
The compounds were screened for their antibacterial activity against strains Staphylococcus aureus
Mau 29/58, Escherichia coli Ec 377/79 and Candida albicans45 strains originated from the former
Czechoslovak Type Culture Collection in Prague. The compounds were tested in diluted culture media
(nutrient broth for bacteria, Sabouraud’s medium for fungi). Serial dilutions of the compounds under study
were prepared in the culture media and 24 hr culture of microorganisms was added to each dilution. After 24
h cultivation (bacteria 37 C, fungi 25 C) minimum inhibitory concentration (MIC) [Bg/ml] was
determined for each compound as the lowest concentration which was capable of stopping the microbial
growth. For evaluation of the biological activity the compounds with the MIC upto 100 Bg/ml were
considered as very good active, compounds with MIC in the range 100 1000 Bg/ml were considered to
possess good biological activity, compounds with MIC in the range 1000 5000 pg/ml weak, and if MIC is
above 5000 Bg/ml the compound were taken as biologically inactive.
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RESULTS AND DISCUSSION
On the basis of the results of X-ray diffraction and/or IR spectra published elsewhere (see Table 1),
the structural types were assigned to the studied compounds (see Fig. and Table 1). In case only IR
spectral data were available, the assignment was based on:
(i) comparisons of the IR spectra made within a series of closely related compounds, several of which
have X-ray structural data available
(ii)the fact that for unidentate coordination of carboxylate group inequality both of C-O bonds is
characteristic and therefore a larger value of carboxylate separation (>170 cm-), defined as
A=v,s(COO)-vs(COO), is observed in comparison to bidentate mode of coordination
H20 OH
O--b_n"___O
/IN
RIC----O O-----CR
A
Compound II
0 L .
C" L/
.O__.C! or R
/
0 L
L, kl water or organic ligand
Compounds III, IV, V, Vl, Xl, Xll
O,cN
H
/c
o "\o
X..Zn.....X
O -/0
c
I+CH
H2N’%0
X=CI- Br- I-
C
Compounds VII, XlII, XlV
OX- ICH o.ml rZn
2c. n)0
_/ c n Zn
Zn
Compound
D
Compounds VIII, IX, X
Fig. 1" The structural types assigned to the prepared compounds
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For example, in zinc acetate dihydrate (!I), the value of separation of the carboxylate stretches, A= 108
cm [19]. This value characterizes the bidentate mode of carboxylate coordination and it is in agreement with
the results of X-ray diffraction [20]. In the substituted analogues Zn(CICHsCOO)z.2H:O (V) and
Zn(BrCH2COO)2o2HsO (VI) the A values (196 cm) were rather higher in comparison to
Zn(CHCOO)2.2H_O (see Table 1), indicating monodentate carboxylate coordination and molecular structure
of the compound.
On the contrary to the chioro- and bromo- derivatives, in zinc iodoacetate Zn(ICHsCOO)_ (VII), the
value of separation of carboxylate stretches, A=144 cm, characterizes the bidentate mode of carboxylate
coordination. Moreover, splitting of both carboxylate stretches observed in the sample, indicated the presence
of carboxylate bridges (syn-syn or syn-anti) [21]. Therefore, two-dimensional structure was assigned to the
zinc(II) iodoacetate, similarly to the structure of anhydrous zinc acetate Zn(CHCOO)_, where syn-anti
bridges are present [22]. The salne method was applied to the assignment of the structural types to the other
prepared compounds. The values of separation of-CO: stretches and assigned structural types are summarized
in Table and shown in Fig. 1.
Table 1. The values of the separation of the -CO2 stretches and assignment of the structural types to the
studied compounds
Compound ,, A=Vas(COO’)-vs(CO0") Structural type* Ref.
II
Zn(HCOO),_.2H20
Zn(CH3COO)_,.2H_O (il)
[Zn(CH3COO)2(Nia)2].2H_O
[Zn(CH3COO)2(Caf)2].2H_O
,,Zn(c cH,_COO)_.2 H,_O (V)
Zn(BrCH_,COO)2.2H20 (Vl)
....Zn(ICH2COO)2 (Vii),
[ZnC I_(N ia*CH2COO-)2]
[ZnBr2(N ia+CH2COO)_,
[Zn I2(Nia+CH2COO)_] (X)
[Zn(CIH2COO)ffCaf)_].2H20 (XI)
[Zn(BrCH2COO),_(Caf)2].2H20 (Xil)
Zn(CH3CH2CH.,COO),_ (Xlll)
,Zn((CH3)2CHCOO)2
Abbreviations"
152 3D
108 M
172 M
170 M
196 M
196 M
144 2D
276 M
276 M
280 M
200 M
188 M
130 2I)
(XIV) 140 2D
* structure assigned on the basis of spectral data and X-ray diffraction
** structure assigned on the basis of spectral data
M molecular structure
2D- two-dimensional structure
3D- three-dimensional structure
23
19, 20
18
10
13
18
18, 22
15, 16
11,16
14, 16
13
18
24
17
Antimicrobial activiO,
The results of testing of antibacterial and antifungal activity of the prepared compounds against
bacterial strains Staphylococcus aureus, Escherichia coli and yeast Candida albicans are summarized in
Table 2.
From the Table 2 it can be seen, that the zinc(II) carboxylates have the highest efficiency on the
Gram-positive bacteria Staphylococcus aureus. The efficiency on the Gram-negative bacteria Escherichia coli
is lower and that on the fungi Candida albicans is negligible.
The influence of the carboxylate chain length on the biological activity is shown in Fig. 2. The
increasing of the carboxylate chain length may affect the lipophillicity of the molecule. In general, as the
chain length increases lipophillicity of the compound increases and its solubility in the water decreases.
From the Fig. 2 it is obvious that the length of the carboxylate chain affects the activity of the zinc(II)
carboxylates neither against the Staphylococcus aureus, nor Escherichia coli. This is probably due to low
thermodynamic stability of the compounds and their dissociation to ions in the solution.
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Table 2. Antimicrobial activity of the studied compounds (MIC in tg/n
Compund !! S. aureus
Zn(HCOO)2.2HiO (!) 312
Zn(CH3COO)2.2H,_O
[Zn(CH3COO),_(N ia)_,].2H20 (111)
[Zn(CH3C.OO)2(Caf)2]’2H20, (IV)
Zn(CICH2COO)2.2H20
Zn(BrCH2COO),.o2H20
,,Zn(ICH,_COO)2 (VII).
...[ZnCI2(N ia CH2COO)i1
[ZnBr2(Nia+CH2COO)2
[Znl, N ,.COO),_] (X) _(. ia+CH
[Zn(C H,COO)_(Caf)_].2H_O
[Zn(BrCH2COO)_,(Caf)2].2H_O
Zn(CH3CH2CHzCOO)2 (Xlli)
Zn((CH3)2CHCOO)_, (XIV)
312
1250
5000
312
156
78
625
1250
1250
1250
625
.12
.12
E. coli
5000
5000
5000
>5000
2500
312
312
5000
>5000
2500
500O
1250
5000
5000
C. albicans
625
1250
5000
>5000
1250
1250
1250
2500
2500
5000
5000
2500
5000
5000
The efficiency of these four carboxylates against Staphylococcus aureus is good, but almost no
inhibitory effect was observed on Escherichia coli. In the case of yeast Candida albicans there is evident
lowering of efficiency from formiate to butyrate. Zinc formiate exhibits good efficiency, the biological
activity of the butyrate and isobutyrate is very low. No effect was observed in connection with the branching
of the carboxylate chain (Xlii, XIV).
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Fig. 2. The influence of the carboxylate chain length on the biological activity
The influence of the substitution of the hydrogen atom of the zinc(ll) acetate by halogen is illustrated
in Fig. 3. The presence of halogen atom in the molecule can affect the biological activity of the compound
by steric or electron effects. As it is obvious from Fig. 3 substitution of the hydrogen atom has no or
minimal effect for yeast Candida albicans. In the case of both bacterial strains the efficiency increases in the
order of H < CI < Br < I. From overall point of view the compounds Zn(XCH2COO)2"nH20 (X=CI, Br, I;
n=0, 2) have the best activity against Staphylococcus aureus, medium activity against Candida albicans and
their activity in the case of Escherichia coil rises in the order Zn(CH3COO)_,’2H_,O < Zn(CICH_,COO)2,2H20
< Zn(BrCH_,COO)2o2H_,O < Zn(ICH2COO)2. The similar results were observed in the study of copper
carboxylates, where efficiency of the compounds linearly increases with the substituting halogen F < CI < Br
< [251.
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Fig. 3. The influence of the halogen atom on the biological activity of zinc(II) carboxylates
The organic ligands can contribute to the better transport of metal ions through the lipophillic regions
of cell membranes. The influence of ligands nicotinamide and caffeine on the biological activity is shown in
Fig. 4. Nicotinamide and caffeine complexes did not exhibit any higher efficiency compared with the simple
zinc(ll) carboxylates and mbstly their efficiency even decrease. The same negative effect of the organic
molecule on the efficiency of carboxylates was observed by Melnik et al who studied copper carboxylates
with antipyrine [25].
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Fig. 4. The influence of the ligands on the biological activity of zinc(II) carboxylates
The nicotinamide complexes are more effective than the caffeine complexes. The efficiency of the
complexes decreases in the order Staphylococcus aureus > Candida albicans > Escherichia coll. The
positive effect of the halogen atom on the efficiency of the complexes, described already above, can be
observed again in Fig. 4.
In conclusion, no correlation can be made between assigned structural types (see Fig. I) and
biological activity. This is probably due to the low thermodynamic stability of the prepared compounds,
their dissociation in the solution and consequently lower permeability through cell membranes.
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